BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 31786890)

  • 1. A four-gene expression-based signature predicts the clinical outcome of melanoma.
    Sun L; Li P; Ren H; Liu G; Sun L
    J BUON; 2019; 24(5):2161-2167. PubMed ID: 31786890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting the clinical outcome of melanoma using an immune-related gene pairs signature.
    Meng L; He X; Zhang X; Zhang X; Wei Y; Wu B; Li W; Li J; Xiao Y
    PLoS One; 2020; 15(10):e0240331. PubMed ID: 33031392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melanoma long non-coding RNA signature predicts prognostic survival and directs clinical risk-specific treatments.
    Chen X; Guo W; Xu XJ; Su F; Wang Y; Zhang Y; Wang Q; Zhu L
    J Dermatol Sci; 2017 Mar; 85(3):226-234. PubMed ID: 27955882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of hypoxia signature to predict prognosis and the tumor immune microenvironment in melanoma.
    Shou Y; Yang L; Yang Y; Zhu X; Li F; Xu J
    Mol Omics; 2021 Apr; 17(2):307-316. PubMed ID: 33624645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A miRNA-Based Signature Detected in Primary Melanoma Tissue Predicts Development of Brain Metastasis.
    Hanniford D; Zhong J; Koetz L; Gaziel-Sovran A; Lackaye DJ; Shang S; Pavlick A; Shapiro R; Berman R; Darvishian F; Shao Y; Osman I; Hernando E
    Clin Cancer Res; 2015 Nov; 21(21):4903-12. PubMed ID: 26089374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A four-DNA methylation biomarker is a superior predictor of survival of patients with cutaneous melanoma.
    Guo W; Zhu L; Zhu R; Chen Q; Wang Q; Chen JQ
    Elife; 2019 Jun; 8():. PubMed ID: 31169496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The nucleosome remodeling and deacetylase complex has prognostic significance and associates with immune microenvironment in skin cutaneous melanoma.
    Liu X; Wang J
    Int Immunopharmacol; 2020 Nov; 88():106887. PubMed ID: 32799111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and Validation of Prognostically Relevant Gene Signature in Melanoma.
    Gao Y; Li Y; Niu X; Wu Y; Guan X; Hong Y; Chen H; Song B
    Biomed Res Int; 2020; 2020():5323614. PubMed ID: 32462000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A six-long non-coding RNA signature predicts prognosis in melanoma patients.
    Yang S; Xu J; Zeng X
    Int J Oncol; 2018 Apr; 52(4):1178-1188. PubMed ID: 29436619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a prognostic genetic signature to predict the metastatic risk associated with cutaneous melanoma.
    Gerami P; Cook RW; Wilkinson J; Russell MC; Dhillon N; Amaria RN; Gonzalez R; Lyle S; Johnson CE; Oelschlager KM; Jackson GL; Greisinger AJ; Maetzold D; Delman KA; Lawson DH; Stone JF
    Clin Cancer Res; 2015 Jan; 21(1):175-83. PubMed ID: 25564571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and verification of a ten-gene signature predicting overall survival for ovarian cancer.
    Liu J; Xu F; Cheng W; Gao L
    Exp Cell Res; 2020 Oct; 395(2):112235. PubMed ID: 32805252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel Prognostic Factor for Uveal Melanoma: Bioinformatics Analysis of Three Independent Cohorts.
    Choi S; Ha M; Lee JS; Heo HJ; Kim GH; Oh SO; Lee JJ; Goh TS; Kim YH
    Anticancer Res; 2020 Jul; 40(7):3839-3846. PubMed ID: 32620623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a survival-related signature for sarcoma patients through integrated transcriptomic and proteomic profiling analyses.
    Zhang B; Yang L; Wang X; Fu D
    Gene; 2021 Jan; 764():145105. PubMed ID: 32882333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular characterization of lung adenocarcinoma: A potential four-long noncoding RNA prognostic signature.
    Sui J; Yang S; Liu T; Wu W; Xu S; Yin L; Pu Y; Zhang X; Zhang Y; Shen B; Liang G
    J Cell Biochem; 2019 Jan; 120(1):705-714. PubMed ID: 30125988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of prognostic genes in uveal melanoma microenvironment.
    Luo H; Ma C
    PLoS One; 2020; 15(11):e0242263. PubMed ID: 33196683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel lncRNA-focus expression signature for survival prediction in endometrial carcinoma.
    Zhou M; Zhang Z; Zhao H; Bao S; Sun J
    BMC Cancer; 2018 Jan; 18(1):39. PubMed ID: 29304762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A five-gene signature may predict sunitinib sensitivity and serve as prognostic biomarkers for renal cell carcinoma.
    Chen YL; Ge GJ; Qi C; Wang H; Wang HL; Li LY; Li GH; Xia LQ
    J Cell Physiol; 2018 Oct; 233(10):6649-6660. PubMed ID: 29327492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-platform comparison of independent datasets identifies an immune signature associated with improved survival in metastatic melanoma.
    Lardone RD; Plaisier SB; Navarrete MS; Shamonki JM; Jalas JR; Sieling PA; Lee DJ
    Oncotarget; 2016 Mar; 7(12):14415-28. PubMed ID: 26883106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A large cohort study identifying a novel prognosis prediction model for lung adenocarcinoma through machine learning strategies.
    Li Y; Ge D; Gu J; Xu F; Zhu Q; Lu C
    BMC Cancer; 2019 Sep; 19(1):886. PubMed ID: 31488089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a 4-mRNA metastasis-related prognostic signature for patients with breast cancer.
    Xie X; Wang J; Shi D; Zou Y; Xiong Z; Li X; Zhou J; Tang H; Xie X
    J Cell Mol Med; 2019 Feb; 23(2):1439-1447. PubMed ID: 30484951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.